Search For "biopharmaceutical"
Phase 2,3 trial data of India's first mRNA COVID vaccine submitted to DCGI
Updated : 3 years, 12 months ago IST
New Delhi [India], March 18 (ANI): Pune-based Gennova Biopharmaceuticals has submitted the phase-II and phase-III trials data of India's first mRNA COVID vaccine to the regulator Drugs Controller General of India (DCGI) on Friday, said sources.
Read More
mRNA vaccine testing for Omicron subject to regulatory approvals: Gennova
Updated : 4 years, 1 month ago IST
New Delhi [India], January 17 (ANI): The testing of Gennova Biopharmaceutical's mRNA vaccine for the Omicron variant of COVID-19 is subject to regulatory approvals, the company's official spokesperson informed on Monday.
Read More
India's first homegrown mRNA vaccine to be tested amid Omicron spike: Offi
Updated : 4 years, 1 month ago IST
New Delhi [India], January 17 (ANI): The country's first messenger mRNA vaccine is expected to begin trials on humans in February.
Read More
Silexon partners with Excelra, deploying GOSTAR to strengthen its AI-drive
Updated : 4 years, 3 months ago IST
Telangana (Hyderabad) [India]/Nanjing [China], December 1 (ANI/PR Newswire): Excelra, a leading global data & analytics provider, today announced its partnership with Silexon AI Technology, a next-generation biotech company with a scalable AI/ML (Artificial Intelligence and Machine Learn
Read More
Bugworks Research announces the first in Human Phase 1 Study of BWC0977 fo
Updated : 4 years, 4 months ago IST
Bengaluru (Karnataka) [India]/ Saratoga (California) [US]/ Adelaide [Australia], November 8 (ANI/PRNewswire): Bugworks research today announced that the first human dose was administered in a Phase 1 clinical trial evaluating BWC0977: a next generation broad-spectrum, novel bacterial topoiso
Read More
Study: Small amounts of carbon monoxide may help protect vision in diabete
Updated : 4 years, 4 months ago IST
Washington [US], November 6 (ANI): The Medical College of Georgia scientists have early evidence that HBI-002, a low-dose oral compound developed by Hillhurst Biopharmaceuticals and already in early-stage trials for sickle cell disease, can safely reduce oxidative stress and inflammation in
Read More
Foreign bio raw and subsidiary materials companies to invest 400 billion w
Updated : 4 years, 4 months ago IST
Seoul [South Korea], November 4 (ANI/Global Economic): Global biopharmaceutical raw and subsidiary material suppliers are announcing investment plans in Korea. As companies convert to 'local production' strategy due to the shortage of bio-materials, components, and equipment during the pande
Read More
SII announces strategic partnership with Biocon Biologics
Updated : 4 years, 5 months ago IST
New Delhi [India], September 17 (ANI): Hoping to strengthen India's position as a global vaccine and biologics manufacturing powerhouse, COVID-19 vaccine Covishield maker Serum Institute of India (SII) announced a strategic alliance with biopharmaceutical company Biocon Biologics Limited (BB
Read More
Ocugen Inc to have exclusive co-development, manufacturing rights of Covax
Updated : 4 years, 9 months ago IST
Hyderabad (Telangana) [India], June 3 (ANI): Hyderabad-based Bharat Biotech on Thursday said that biopharmaceutical company Ocugen Inc will have exclusive co-development, manufacturing, and commercialisation rights of its COVID-19 vaccine Covaxin in Canada, in addition to its existing Uni
Read More
Centre to augment manufacturing capacity of COVAXIN under Mission COVID Su
Updated : 4 years, 10 months ago IST
New Delhi [India], May 12 (ANI): Amid the reports of shortage of Bharat Biotech's COVID-19 vaccine, the Centre on Wednesday said it will double the current production capacity of COVAXIN by May-June and then increase it to nearly six to seven folds by July-August. The government of India sai
Read More
Global sales of Celltrion's COVID-19 antibody-drug Regkirona begin
Updated : 4 years, 10 months ago IST
Seoul [South Korea], May 12 (ANI/Global Economic): Worldwide sales of Regkirona (active ingredient: regdanvimab), a COVID-19 antibody drug developed by South Korean biopharmaceutical company Celltrion Inc, has begun.
Read More
Third consignment of 25000 doses of Remdesivir from Gilead sciences reache
Updated : 4 years, 10 months ago IST
New Delhi [India], May 8 (ANI): The third consignment consisting of 25000 doses of Remdesivir from American biopharmaceutical company Gilead Sciences reached India on Saturday.
Read More